This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Keren, A. Articles by Popp, R. L. Search for Related Content PubMed PubMed Citation Articles by Keren, A. Articles by Popp, R. L.

Circulation, Vol 81, 506-517, Copyright © 1990 by American Heart Association

ARTICLES

Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation

A Keren, S Gottlieb, D Tzivoni, S Stern, R Yarom, ME Billingham and RL Popp
Heiden Department of Cardiology, Bikur Cholim Hospital, Jerusalem, Israel.

Prognosis in classically described dilated congestive cardiomyopathy has been reported to be related to ventricular size. Mildly dilated congestive cardiomyopathy (MDCM) has been defined as end-stage heart failure of unknown etiology (New York Heart Association class IV, left ventricular ejection fraction less than 30%), occurring with neither typical hemodynamic signs of restrictive myopathy nor significant ventricular dilatation (less than 15% above normal range). The present study includes follow-up in 12 nontransplant patients. In the first 4 months after diagnosis, two patients improved and are living, and two showed cardiac dilation and clinical deterioration and died. Six of the remaining eight with persistent MDCM died (four with intractable heart failure and two, sudden deaths) without change in ventricular size before death, despite medical therapy over 20 +/- 8 months. Eight comparable transplanted patients with persistent MDCM demonstrated improved total survival by life table analysis (p less than 0.05). A family history of congestive cardiomyopathy was found in nine of 16 patients (56%) with persistent MDCM. Nontransplant patients were older (p less than 0.02), but other findings were similar in the two groups. Endomyocardial biopsies available in 14 of 16 cases showed little or no myofibrillar loss in spite of severe hemodynamic impairment. The degree of myofibrillar loss did not correlate with hemodynamic parameters but showed good correlation with left ventricular size, that is, five of six patients with no myofibrillar loss had normal ventricular size, whereas all eight patients with mild myofibrillar loss had mild cardiomegaly (p less than 0.002). Our current experience suggests a somewhat variable but negative prognosis after prospective diagnosis of MDCM, with poor survival in patients with persistence of the original diagnostic features during follow-up. Preservation of heart size in MDCM is probably related to lack of significant myofibrillar loss. Thus, irrespective of heart size or myofibrillar preservation on biopsy, heart transplantation should be strongly considered in MDCM if signs of severe cardiac dysfunction persist despite therapy.

This article has been cited by other articles:

				P. Elliott, B. Andersson, E. Arbustini, Z. Bilinska, F. Cecchi, P. Charron, O. Dubourg, U. Kuhl, B. Maisch, W. J. McKenna, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases Eur. Heart J., January 2, 2008; 29(2): 270 - 276. [Abstract] [Full Text] [PDF]

				E. L. Burkett and R. E. Hershberger Clinical and genetic issues in familial dilated cardiomyopathy J. Am. Coll. Cardiol., April 5, 2005; 45(7): 969 - 981. [Abstract] [Full Text] [PDF]

				M. R. G. Taylor, P. R. Fain, G. Sinagra, M. L. Robinson, A. D. Robertson, E. Carniel, A. Di Lenarda, T. J. Bohlmeyer, D. A. Ferguson, G. L. Brodsky, et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations J. Am. Coll. Cardiol., March 5, 2003; 41(5): 771 - 780. [Abstract] [Full Text] [PDF]

				A. Gavazzi, A. Repetto, L. Scelsi, C. Inserra, M.L. Laudisa, C. Campana, C. Specchia, B. Dal Bello, M. Diegoli, L. Tavazzi, et al. Evidence-based diagnosis of familial non-X-linked dilated cardiomyopathy. Prevalence, inheritance and characteristics Eur. Heart J., January 1, 2001; 22(1): 73 - 81. [Abstract] [PDF]

				S Di Somma, M Marotta, G Salvatore, G Cudemo, G Cuda, F De Vivo, M P Di Benedetto, F Ciaramella, G Caputo, and O de Divitiis Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans Heart, December 1, 2000; 84(6): 659 - 667. [Abstract] [Full Text]

				G. M. Felker, J. P. Boehmer, R. H. Hruban, G. M. Hutchins, E. K. Kasper, K. L. Baughman, and J. M. Hare Echocardiographic findings in fulminant and acute myocarditis J. Am. Coll. Cardiol., July 1, 2000; 36(1): 227 - 232. [Abstract] [Full Text] [PDF]

				G Yi, K Hnatkova, N.G Mahon, P.J Keeling, M Reardon, A.J Camm, and M Malik Predictive value of wavelet decomposition of the signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy Eur. Heart J., June 2, 2000; 21(12): 1015 - 1022. [Abstract] [PDF]

				L. Mestroni, C. Rocco, D. Gregori, G. Sinagra, A. Di Lenarda, S. Miocic, M. Vatta, B. Pinamonti, F. Muntoni, A. L. P. Caforio, et al. Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity J. Am. Coll. Cardiol., July 1, 1999; 34(1): 181 - 190. [Abstract] [Full Text] [PDF]

				N G Fisher and A J Marshall Management options: Anthracycline-induced cardiomyopathy Postgrad. Med. J., May 1, 1999; 75(883): 265 - 268. [Abstract] [Full Text]

				A. Pelliccia, F. Culasso, F. M. Di Paolo, and B. J. Maron Physiologic Left Ventricular Cavity Dilatation in Elite Athletes Ann Intern Med, January 5, 1999; 130(1): 23 - 31. [Abstract] [Full Text] [PDF]

				T. Suzuki, T. Kanda, H. Nagaoka, S. Kubota, T. Iizuka, R. Nagai, I. Kobayashi, and T. Suzuki Predictive Value of Left Ventricular Response to Exercise in Patients with Dilated Cardiomyopathy: Assessment by Radionuclide Ventriculography Angiology, June 1, 1997; 48(6): 497 - 502. [Abstract] [PDF]

				J.-B. Durand, L. L. Bachinski, L. C. Bieling, G. Z. Czernuszewicz, A. B. Abchee, Q. Tao Yu, T. Tapscott, R. Hill, J. Ifegwu, A.J. Marian, et al. Localization of a Gene Responsible for Familial Dilated Cardiomyopathy to Chromosome 1q32 Circulation, December 15, 1995; 92(12): 3387 - 3389. [Abstract] [Full Text]

				G. W. Dec and V. Fuster Idiopathic Dilated Cardiomyopathy N. Engl. J. Med., December 8, 1994; 331(23): 1564 - 1575. [Full Text]

				D. D. Sugrue, R. J. Rodeheffer, M. B. Codd, D. J. Ballard, V. Fuster, and B. J. Gersh The Clinical Course of Idiopathic Dilated Cardiomyopathy: A Population-based Study Ann Intern Med, July 15, 1992; 117(2): 117 - 123. [Abstract] [PDF]